Safety and efficacy of Igk-TATk-CDKL5 gene therapy in mosaic CDKL5 deficiency

Abstract excerpt

CDKL5 Deficiency Disorder (CDD) is a severe neurodevelopmental disorder caused by mutations in the X-linked CDKL5 gene, resulting in early-onset seizures, developmental delays, and cognitive and sensorimotor impairments. While emerging therapies show promise, substantial challenges remain in developing a cure for CDD. In our prior work, we developed an innovative gene therapy strategy based on an Igk-TATk-CDKL5...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Chronic Lymphocytic Leukemia Research
• Share to Genetics and Neurodevelopmental Disorders
• Share to Immunodeficiency and Autoimmune Disorders